ArcelorMittal has extended its August recovery into September, but a modest rise in borrowing costs introduces a small new wrinkle worth tracking.
The stock added 1.9% on the week to close at €63.74, building on the 6.1% monthly recovery noted last week. That puts the name around 17% below the analyst consensus target of €76.96 — an unchanged gap that continues to represent meaningful potential upside for a steelmaker in a sector where growth-fund interest is typically limited. The July quarterly print was well-received: MT rose 5.1% on the day and 10.5% over the five sessions that followed, and the next result isn't due until November 5, leaving a relatively quiet calendar ahead.
The borrow market remains extremely loose, but the cost of borrowing has started to move. Availability is still at its statistical ceiling — effectively every share in the lending pool remains available — so there is no meaningful short pressure building. Yet cost to borrow has risen about 30% over the past week to 0.85%, after sitting in a narrow 0.50%–0.70% band for most of the summer. That is still objectively cheap, and the ORTEX short score of 25.3 ranks in the bottom 6% of the universe — short-side conviction is negligible. The uptick in borrow cost is therefore less a bear signal and more a data point to monitor: it may simply reflect end-of-month repo mechanics rather than new shorting intent.
The fundamental picture remains the standout. The forward EPS revision cycle is sharply positive — the 12-month forward earnings growth factor ranks in the 86th percentile — and earnings momentum is strong both on a 30-day and 90-day basis. The P/E has drifted up slightly to around 11.5x over the past month, reflecting the stock's recovery, while EV/EBITDA has actually eased a touch to 6.8x. The dividend score ranks in the 99th percentile, and the €0.15 quarterly cash dividend continues to provide a floor for income-oriented holders. The consensus remains constructive, though no fresh analyst changes have been filed since mid-August.
The ownership picture is distinctive. Grandel Pte Limited — the Mittal family vehicle — holds 45% of shares, a controlling stake confirmed by a Schedule 13D/A filing from Lakshmi N. Mittal in March. That filing is the most newsworthy structural fact about MT's register. Founder-control at this level limits the free float and constrains the short opportunity mechanically, which is consistent with the near-zero borrow activity seen all year. Among the institutional base, FMR (Fidelity) added 2.55 million shares in the latest filing period, the largest reported increase among named holders, while Capital Research built by 4.6 million shares as of end-June — both moves suggesting active managers have been adding into the stock's weakness earlier in the year.
Within the peer group, the week was mixed for metals names. SZG outperformed with a 5.5% weekly gain, while ANTO and KGH both fell more than 4%, reflecting diverging fortunes across base and industrial metals. MT's 1.9% gain was a reasonable middle ground in that context.
The key variable to watch into November is whether the cost-to-borrow trend continues higher or reverts — a sustained move above 1% would be the first meaningful signal that short interest is beginning to build in a name that has, until now, attracted almost none.
See the live data behind this article on ORTEX.
Open MT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
